Baker Bros. Advisors LP Acadia Pharmaceuticals Inc Transaction History
Baker Bros. Advisors LP
- $7.52 Billion
- Q2 2024
A detailed history of Baker Bros. Advisors LP transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Baker Bros. Advisors LP holds 42,877,916 shares of ACAD stock, worth $689 Million. This represents 9.26% of its overall portfolio holdings.
Number of Shares
42,877,916
Previous 42,864,612
0.03%
Holding current value
$689 Million
Previous $793 Million
12.09%
% of portfolio
9.26%
Previous 10.04%
Shares
12 transactions
Others Institutions Holding ACAD
# of Institutions
288Shares Held
161MCall Options Held
723KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA13.7MShares$220 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY13.7MShares$220 Million3.72% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$194 Million0.0% of portfolio
-
State Street Corp Boston, MA5.8MShares$93.2 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.71MShares$59.6 Million0.17% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.6B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...